Le Lézard
Classified in: Health
Subjects: WOM, RCL

Mason Vitamins Inc. Voluntary Recalls Healthy Sense Daily Multiple with Iron tablets and People's Choice Women's Daily Vitamins with Iron tablets sold in the U.S due to inconsistent product labeling with the product


MIAMI LAKES, Fla., Nov. 18, 2022 /PRNewswire/ -- Mason Vitamins Inc. has issued a nationwide voluntary recall of the specific lot of Healthy Sense Daily Multiple with Iron and People's Choice Women's Daily Vitamins with Iron due to Vitamin A, Vitamin B12, Vitamin C, Vitamin E and Pantothenic Acid amounts being lower than the declared amount on the label which was determined during an FDA inspection.

The products were sold nationwide at Bargain Barn, 99 Cents Only, Fruth Pharmacy, Joe V's Smart Shop, Rose's Discount Stores, Rex Discount Pharmacy, Star Discount Pharmacy, Propst Discount Pharmacy, Dollar Tree and limited distributors.

Product Name

Size

UPC Code

Lot/Expiration Date

Healthy Sense Daily Multiple with Iron

20 tablets

311845353238

25807G / 09/2024

People's Choice Women's Daily
Vitamins with Iron

30 tablets

311845486882

25807G / 09/2024

A25807G / 09/2024

B25807G / 09/2024

C25807G / 09/2024

D25807G / 09/2024

To date, no illnesses related to these products have been reported. No other People's Choice and Healthy Sense products are affected by this recall. If customers have product affected by this voluntary recall, they should discard it immediately.

For any additional information, please call Customer Care 1-888-860-5376, Monday through Friday 9:00 AM to 5:00 PM EST. We regret any inconvenience this may cause.

Contact:

[email protected]
1-888-860-5376

SOURCE Mason Vitamins


These press releases may also interest you

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...

at 07:00
XORTX Therapeutics Inc. ("XORTX" or the "Company") , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that further to its press releases of March 11 and April 30,...

at 06:18
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...



News published on and distributed by: